Overview
Obligated since award on contracts active FY2021–FY2026
Click a company to open its profile.
Insight NATIONAL INSTITUTES OF HEALTH NIAID (75N930) is its largest buyer. See more on the Buyers tab
Agencies report with a delay; the latest year will rise
Hover over a year to see its value.
Insight Largest year: $2.2M in FY2020; since FY2021, $355K in FY2025. See more on the Contracts tab
$4.45M since award = $300K in FY2021–FY2026 + $4.15M before FY2021
Click a state to open its page.
- Georgia$4.45M · 100%
Insight 100% was performed in Georgia. See more on the Contracts tab
Contracts
2 contracts with an action since FY2021
Click a bar to open its contract.
Insight Stand-alone contracts hold 100% of these contracts' obligations.
Current end date of each prime contract with an action since FY2021
Hover over a month to see its value.
Metaclipse Therapeutics Corp. prime contracts with an action in FY2021–FY2026
Find a contract by vehicle, office or end date; sort by money to see the largest.
0 end within 12 months.
Showing 1–2 of 2 contracts
| Since award, US$ | |||||
|---|---|---|---|---|---|
| Parent contract (IDVIDV: the record type for any contract that exists to take orders: IDIQs, GWACs, GSA Schedules, BPAs and basic ordering agreements. Glossary) | ObligatedObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary | ||||
| 75N93019C00017 | Stand-alone | NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | $4,148,210 | Dec 31, 2022 | Ended |
| 75N91025C00038 | Stand-alone | NIH NCI (75N910) | $299,984 | Sep 4, 2026 | Ended |
Buyers
National Institutes of Health: $4.45M obligated since award; $355K in FY2021–FY2025 actions
Click a bar to open its office page.
Insight National Institutes of Health placed 100%.
Contracting offices that awarded Metaclipse Therapeutics prime contracts, FY2021–FY2026
See which offices award its contracts.
2 offices awarded only one contract.
Showing 1–2 of 2 offices
| Contracts active FY2021–FY2026; obligated since award, US$ | |||||
|---|---|---|---|---|---|
| NATIONAL INSTITUTES OF HEALTH NIAID (75N930) | National Institutes of Health | 1 | $4,148,210 | Aug 13, 2019 | Aug 25, 2022 |
| NIH NCI (75N910) | National Institutes of Health | 1 | $299,984 | Sep 4, 2025 | Aug 11, 2026 |
Opportunities
Open opportunities matching Metaclipse Therapeutics Corp.'s registered industries
Notices in its 1 industry (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary): 541713
0 of the next 1 are due within 30 days.
Showing 1–1 of 1 opportunity
| Opportunity | Agency | Due |
|---|---|---|
| ERIS Shopping Notice: High Duty Cycle High Energy Lasers (HEL) for SWaP-Constrained Systems (opens in Procura)Special Notice · NAICS 541713Free account: full notice, dates, attachments Contacts · paid plans | Defense Advanced Research Projects Agency (DOD)DEF ADVANCED RESEARCH PROJECTS AGCY (HR0011) | Nov 30, 2026 |
Registration and contacts
Registration
- UEI
- MU6JZBDZR8X1
- CAGE code
- 6BYQ1
- Registration
- Active, expires Jun 9, 2027
- Entity type
- Corporate Entity (Not Tax Exempt)
- Location
- Atlanta, GA, 30316
- Congressional district
- GA-04
Registered industries (NAICSNAICS code: a six-digit code for the kind of work a company does. Each contract carries one, and it sets the small-business size limit. Glossary)
Registered in 1 industry; primary 541713
- 541713 Research and Development in NanotechnologyPrimary
Contacts at Metaclipse Therapeutics Corp.
| Contact | Role | As of |
|---|---|---|
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Government business POC · Electronic business POC · Company contactSAM.gov registrationSBA profileAs of Oct 4, 2026 | Oct 4, 2026 |
| See contactsLocked · 7-day trial or paid plan (name, title and contact details with a 7-day trial or paid plan) | Alternate government business POC · Alternate electronic business POCSAM.gov registrationAs of Jun 11, 2026 | Jun 11, 2026 |
Correct this listing
Tell us what to correct or add on the Metaclipse Therapeutics Corp. page. We check every request before we change a profile.